Evening Straws there is much to like abuot this acquisition and i am keen to hear if there is anything i am missing
BTH was trading 9.3x sales multiple prior to this announcement at 53.1mill in ARR. Market cap 496mill.
FY22 Combines ARR is estimated to come in at 119mill (growth rate estimated to be a combined 20%+in FY22)
On a sales mutilple of
9.3 = 1,106 bill
7= 833mill
5 = 595mill
Other positive considerations :
Synergies estimated to be 3mill+ in FY22
Upsell opportunites across both businesses
SQN Investor uptake of another 35mill shares at $1.05 to 75million shares or 13.9% of total stock providing clear signal on the attractiveness of the deal
Further US focus and ability to compete further enhanced
BTH maintain 72mill in cash
Risk / Downside:
Dilution of stock with additional 129mill more shares on issue.
Execution
Summary
I feel there is low downside risk and solid upside opportunity in short , medium and long term.